The best stocks to buy since 1993

Latest issue now available

Ergomed - Forecasts lifted again - by 5%

July 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ERGO
  • Price:
  • 420p
Ergomed has continued to sail majestically on through the COVID-19 crisis with last month’s AGM told that it saw a strong Q1 with “solid overall growth in revenue” whilst cash generation remained strong. Meanwhile, Q2 impacts from COVID-19 seem broadly positive. Ergomed continued to grow the order book and its staff successfully adapted to remote working conditions with the CRO site monitoring visits conducted virtually during lockdown and no employees were made redundant or furloughed. The PV division has also seen heightened activity levels and is benefiting from the recent acquisition of Ashfield.In the light of the statement, Numis has upgraded its full year expectations by c.5% to £11.9m pretax profit f ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X



To access our archive of articles and to receive current issues you need to subscribe